Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

C J Ross

Showing results (11-20 of 23) with videos related to

Pageof 3
Sort By:
Journal of Biomedical Materials Research|November 25, 1998
Encapsulation of various recombinant mammalian cell types in different alginate microcapsulesM Peirone, C J Ross, G Hortelano, et al.
Human Gene Therapy|October 25, 2000
Treatment of a lysosomal storage disease, mucopolysaccharidosis VII, with microencapsulated recombinant cellsC J Ross, L Bastedo, S A Maier, et al.
Health Education Quarterly|January 1, 1989
Hawaii Asian-American response to the Staying Healthy After Fifty programE Roberts, J I Takenaka, C J Ross, et al.
Clinical Pharmacology and Therapeutics|April 24, 2014
Response to "evaluation of pharmacogenetic markers to predict the risk of Cisplatin-induced ototoxicity"B C Carleton, C J Ross, A P Bhavsar, et al.
Clinical Hemorheology and Microcirculation|December 8, 2010
Image fusion with volume navigation of contrast enhanced ultrasound (CEUS) with computed tomography (CT) or magnetic resonance imaging (MRI) for post-interventional follow-up after transcatheter arterial chemoembolization (TACE) of hepatocellular carcinomas (HCC): Preliminary resultsC J Ross, J Rennert, D Schacherer, et al.
Neurogenetics|June 25, 2014
AIMP1 deficiency presents as a cortical neurodegenerative disease with infantile onsetL Armstrong, R Biancheri, C Shyr, et al.
Clinical Pharmacology and Therapeutics|April 17, 2013
Replication of TPMT and ABCC3 genetic variants highly associated with cisplatin-induced hearing loss in childrenK Pussegoda, C J Ross, H Visscher, et al.
Clinical Pharmacology and Therapeutics|March 9, 2012
Prediction of codeine toxicity in infants and their mothers using a novel combination of maternal genetic markersJ Sistonen, P Madadi, C J Ross, et al.
Clinical Pharmacology and Therapeutics|August 22, 2014
Genetic markers of cisplatin-induced hearing loss in childrenB C Carleton, C J Ross, K Pussegoda, et al.
Clinical Pharmacology and Therapeutics|November 7, 2013
Role of TPMT and COMT genetic variation in cisplatin-induced ototoxicityB C Carleton, C J Ross, A P Bhavsar, et al.
Pageof 3

Showing results (11-20 of 23) with videos related to

Sort By:
Pageof 3
Journal of Biomedical Materials Research|November 25, 1998
Encapsulation of various recombinant mammalian cell types in different alginate microcapsulesM Peirone, C J Ross, G Hortelano, et al.
Human Gene Therapy|October 25, 2000
Treatment of a lysosomal storage disease, mucopolysaccharidosis VII, with microencapsulated recombinant cellsC J Ross, L Bastedo, S A Maier, et al.
Health Education Quarterly|January 1, 1989
Hawaii Asian-American response to the Staying Healthy After Fifty programE Roberts, J I Takenaka, C J Ross, et al.
Clinical Pharmacology and Therapeutics|April 24, 2014
Response to "evaluation of pharmacogenetic markers to predict the risk of Cisplatin-induced ototoxicity"B C Carleton, C J Ross, A P Bhavsar, et al.
Clinical Hemorheology and Microcirculation|December 8, 2010
Image fusion with volume navigation of contrast enhanced ultrasound (CEUS) with computed tomography (CT) or magnetic resonance imaging (MRI) for post-interventional follow-up after transcatheter arterial chemoembolization (TACE) of hepatocellular carcinomas (HCC): Preliminary resultsC J Ross, J Rennert, D Schacherer, et al.
Neurogenetics|June 25, 2014
AIMP1 deficiency presents as a cortical neurodegenerative disease with infantile onsetL Armstrong, R Biancheri, C Shyr, et al.
Clinical Pharmacology and Therapeutics|April 17, 2013
Replication of TPMT and ABCC3 genetic variants highly associated with cisplatin-induced hearing loss in childrenK Pussegoda, C J Ross, H Visscher, et al.
Clinical Pharmacology and Therapeutics|March 9, 2012
Prediction of codeine toxicity in infants and their mothers using a novel combination of maternal genetic markersJ Sistonen, P Madadi, C J Ross, et al.
Clinical Pharmacology and Therapeutics|August 22, 2014
Genetic markers of cisplatin-induced hearing loss in childrenB C Carleton, C J Ross, K Pussegoda, et al.
Clinical Pharmacology and Therapeutics|November 7, 2013
Role of TPMT and COMT genetic variation in cisplatin-induced ototoxicityB C Carleton, C J Ross, A P Bhavsar, et al.
Pageof 3